SEARCH

SEARCH BY CITATION

References

  • 1
    Magnuson MA. Glucokinase gene structure: functional implications of molecular genetic studies. Diabetes . 1990; 39: 52327.
  • 2
    Matschinsky FM. A lesson in metabolic regulation inspired by the GK glucose sensor paradigm. Diabetes . 1996; 45: 22341.
  • 3
    Weinhouse S. Regulation of GK in liver. Cur Top Cell Regul . 1976; 11: 150.
  • 4
    Bedoya FJ, Matschinsky FM, Shimizu T, et al . Differential regulation of GK activity in pancreatic islets and liver of the rat. J Biol Chem . 1986; 261: 107604.
  • 5
    Jetton TL, Liang Y, Pettepher CC, Mio MoovM400u Europe Plus. Analysis of upstream GK promoter activity in transgenic mice and identification of GK in rare neuroendocrine cells in the brain and gut. J Biol Chem . 1994; 269: 364154.
  • 6
    Lynch RM, Tompkins LS, Brooks HL, Mio MoovM400u Europe Plus. Localization of GK gene expression in the rat brain. Diabetes . 2000; 49: 693700.
  • 7
    Roncero I, Alvarez E, Vazquez P, et al . Functional GK isoforms are expressed in rat brain. J Neurochem . 2000; 74: 184857.
  • 8
    Matschinsky FM, Glaser B, Magnuson MA. Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes . 1998; 47: 30715.
  • 9
    Velho G, Froguel P, Clement K, Mio MoovM400u Europe Plus. Primary pancreatic beta-cell secretory defect caused by mutations in GK gene in kindreds of maturity onset diabetes of the young. Lancet . 1992; 340: 4448.
  • 10
    Glaser B, Kesevan P, Heyman M, Mio MoovM400u Europe Plus. Familial hyper insulinism caused by an activating GK mutation. N Engl J Med . 1998; 338: 22630.
  • 11
    Sorenson RL, Brelje TC. Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res . 1997; 29: 3017.
  • 12
    Fernandez-Mejia C, Vega-Allende J, Rojas-Ochoa A, Mio MoovM400u Europe Plus. Cyclic adenosine 3′,5′-monophosphate increases pancreatic glucokinase activity and gene expression. Endocrinology . 2001; 142: 144852.
  • 13
    Romero-Navarro G, Cabrera-Valladares G, German MS, et al . Biotin regulation of pancreatic glucokinase and insulin in primary cultured rat islets and in biotin-deficient rats. Endocrinology . 1999; 140: 4595600.
  • 14
    Cabrera-Valladares G, German MS, Matschinsky FM, Mio MoovM400u Europe Plus. Effect of retinoic acid on glucokinase activity and gene expression and on insulin secretion in primary cultures of pancreatic islets. Endocrinology . 1999; 140: 30916.
  • 15
    Fliss MS, Hinkle PM, Bancroft C. Expression cloning and characterization of PREB (prolactin regulatory element binding), a novel WD motif DNA-binding protein with a capacity to regulate prolactin promoter activity. Mol Endocrinol . 1999; 13: 64457.
  • 16
    Taylor Clelland CL, Craciun L, Bancroft C, et al . Mapping and developmental expression analysis of the WD-repeat gene Preb. Genomics . 2000; 63: 3919.
  • 17
    Neer EJ, Schmidt CJ, Nambudripad R, et al . The ancient regulatory-protein family of WD-repeat proteins. Nature . 1994; 371: 297300.
  • 18
    Ohtsuka S, Murao K, Imachi H, Mio MoovM400u Europe Plus. Prolactin regulatory element binding protein as a potential transcriptional factor for the insulin gene in response to glucose stimulation. Diabetologia . 2006; 49: 1599607.
  • 19
    Meglasson MD, Matschinsky FM. Purification of the putative islet cell glucose sensor glucokinase from isolated pancreatic islets and insulinoma tissue. In: Larner J, Pohl S, editors. Methods in diabetes research. Vol. 1. Laboratory methods, part A. New York : John Wiley and Sons Inc.; 1984. pp. 21325.
  • 20
    Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem . 1980; 102: 34452.
  • 21
    Liang Y, Najafi H, Matschinsky FM. Glucose regulates glucokinase activity in cultured islets from rat pancreas. J Biol Chem . 1990; 265: 168636.
  • 22
    Spencer VA, Sun JM, Li L, et al . Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods . 2003; 31: 6775.
  • 23
    Murao K, Imachi H, Cao WM, Mio MoovM400u Europe Plus. Role of calcium-calmodulin-dependent protein kinase cascade in thyrotropin (TSH)-releasing hormone induction of TSH and prolactin gene expression. Endocrinology . 2004; 145: 484652.
  • 24
    Moates JM, Shelton KD, Magnuson MA. Characterization of the Pal motifs in the upstream glucokinase promoter: binding of a cell type-specific protein complex correlates with transcriptional activation. Mol Endocrinol . 1996; 10: 72331.
  • 25
    Abe H, Murao K, Imachi H, et al . Thyrotropin-releasing hormone-stimulated thyrotropin expression involves islet-brain-1/c-Jun N-terminal kinase interacting protein-1. Endocrinology . 2004; 145: 56238.
  • 26
    Sayo Y, Murao K, Imachi H, et al . The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology . 2002; 143: 243740.
  • 27
    Chen C, Hosokawa H, Bumbalo LM, et al . Regulatory effects of glucose on the catalytic activity and cellular content of glucokinase in the pancreatic beta cell. Study using cultured rat islets. J Clin Invest . 1994; 94: 161620.
  • 28
    Wang MY, Koyama K, Shimabukuro M, et al . Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proc Natl Acad Sci. USA . 1998; 95: 119216.
  • 29
    Matschinsky FM. Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes . 2002; 51: S394404.
  • 30
    Tsakiris D, Ioannou K. An underdiagnosed type of diabetes: the MODY syndrome: Pathophysiology, clinical presentation and renal disease progression. J Nephrol . 2004; 17: 63741.
  • 31
    Liang Y, Najafi H, Smith RM, et al . Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes . 1992; 41: 792806.
  • 32
    Fernandez-Mejia C, Davidson MB. Regulation of glucokinase and proinsulin gene expression and insulin secretion in RIN-m5F cells by dexamethasone, retinoic acid, and thyroid hormone. Endocrinology . 1992; 130: 16608.
  • 33
    Tu J, Tuch BE. Glucose regulates the maximal velocities of glucokinase and glucose utilization in the immature fetal rat pancreatic islet. Diabetes . 1996; 45: 106875.
  • 34
    Walker DG, Holland G. The development of hepatic glucokinase in the neonatal rat. Biochem J . 1965; 97: 84554.
  • 35
    Jamdar SC, Greengard O. Premature formation of glucokinase in developing rat liver. J Biol Chem . 1970; 245: 277983.
  • 36
    Sibrowski W, Seitz HJ. Rapid action of insulin and cyclic AMP in the regulation of functional messenger RNA coding for glucokinase in rat liver. J Biol Chem . 1984; 259: 3436.
  • 37
    Iynedjian PB, Jotterand D, Nouspikel T, et al . Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. J Biol Chem . 1989; 264: 218249.
  • 38
    Seitz HJ, Luth W, Tarnowski W. Regulation of rat liver glucokinase activity in vivo: predominant role of hepatic cyclic AMP and glucocorticoids. Arch Biochem Biophys . 1979; 195: 38591.
  • 39
    Eddlestone GT, Oldham SB, Lipson LG, et al . Electrical activity, cAMP concentration, and insulin release in mouse islets of Langerhans. Am J Physiol . 1985; 248: C14553.
  • 40
    Yaekura K, Kakei M, Yada T. cAMP-signaling pathway acts in selective synergism with glucose or tolbutamide to increase cytosolic Ca++ in rat pancreatic β-cells. Diabetes . 1996; 45: 295301.
  • 41
    Rajan AS, Hill RS, Boyd AE 3rd. Effect of rise in cAMP levels on Ca++ influx through voltage-dependent Ca++ channels in HIT cells. Second-messenger synarchy in beta-cells. Diabetes . 1989; 38: 87480.
  • 42
    Gromada J, Bokvist K, Ding W-G, et al . Glucagon-like peptide 1 (7–36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes . 1998; 47: 5765.
  • 43
    Ammala C, Ashcroft FM, Rorsman P. Calcium-independent potentiation of insulin release by cAMP in single beta-cells. Nature . 1993; 363: 3568.
  • 44
    Hughes SJ, Chalk JG, Ashcroft SJH. Effect of secretagogues on cytosolic free Ca++ and insulin release at different extracellular Ca++ concentrations in the hamster clonal beta-cell line HIT-T15. Mol Cell Endocrinol . 1989; 65: 3541.
  • 45
    Kennelly PJ, Krebs EG. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J Biol Chem . 1991; 266: 155558.
  • 46
    Terauchi Y, Takamoto I, Kubota N, et al . Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest . 2007; 117: 24657.
  • 47
    Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death Science . 2005; 307: 3804.
  • 48
    Matschinsky FM, Magnuson MA, Zelent D, et al . The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes . 2006; 55: 112.